N-benzhydryl quinuclidine compounds are a potent and Src kinase-independent inhibitor of NALCN channels.
Suyun HahnSo Woon KimKi Bum UmHyun Jin KimMyoung Kyu ParkPublished in: British journal of pharmacology (2020)
These findings suggest that N-benzhydryl quinuclidine compounds have a pharmacological potential to directly inhibit NALCN channels and could be a useful tool to investigate functions of NALCN channels.